Hemoglobin-based Oxygen Carrier
PP-007 for Ischemic Stroke
Recruiting1 awardPhase 1
Jacksonville, Florida
This trial tests the safety of PP-007, a modified cow protein given through an IV, in stroke patients. It aims to improve blood flow and reduce brain damage. The study includes patients already receiving standard stroke treatments.
AF Risk EHR Alert for Ischemic Stroke
Recruiting1 award1 criteria
Boston, Massachusetts
This trial will develop and test a clinical AF risk estimation tool to help inform management decisions with ischemic stroke patients. The hypothesis is that cardiac monitoring utilization will be positively correlated with the predicted risk of AF.
Popular Filters
Trials for Ischemic Stroke Patients
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Recruiting2 awardsPhase 3
Austin, Texas
This trial is testing whether it's better to start taking a blood thinner right away or wait a few days after having a stroke. It will also look at whether there are different results for different subgroups of people.
Diuretic
Spironolactone for Stroke Recovery
Recruiting1 awardPhase 2
New Haven, Connecticut
This trial will compare two blood pressure treatment regimens in people who have had a brain hemorrhage. One treatment regimen will include spironolactone and the other will not. Researchers will measure blood pressure levels to see which treatment is more effective.
Trials for Stroke Patients
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Recruiting2 awardsPhase 3
Austin, Texas
This trial is testing whether it's better to start taking a blood thinner right away or wait a few days after having a stroke. It will also look at whether there are different results for different subgroups of people.
Diuretic
Spironolactone for Stroke Recovery
Recruiting1 awardPhase 2
New Haven, Connecticut
This trial will compare two blood pressure treatment regimens in people who have had a brain hemorrhage. One treatment regimen will include spironolactone and the other will not. Researchers will measure blood pressure levels to see which treatment is more effective.
Phase 3 Trials
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Recruiting2 awardsPhase 3
Austin, Texas
This trial is testing whether it's better to start taking a blood thinner right away or wait a few days after having a stroke. It will also look at whether there are different results for different subgroups of people.
Thrombectomy Device
Endovascular Therapy for Ischemic Stroke
Recruiting1 awardPhase 2 & 3
Atlanta, Georgia
This trial will test if removing a blood clot from the brain right after a stroke helps patients with mild symptoms recover better than usual care. It focuses on patients with large clots and mild symptoms shortly after their stroke.
Procedure
Remote Ischemic Preconditioning for Heart Failure
Recruiting0 awardsPhase 2 & 3
Pittsburgh, Pennsylvania
This trial is studying whether a treatment called remote ischemic preconditioning can reduce contrast-associated acute kidney injury, functional capacity, and major adverse kidney events in patients with congestive heart failure undergoing cardiac catheterization and/or percutaneous coronary intervention.
Asundexian for Stroke Prevention
Recruiting1 awardPhase 3
Phoenix, Arizona
This trial is testing asundexian, a new medicine that prevents blood clots, in people who had a non-heart-related stroke or high-risk mini-stroke. The goal is to see if it works better at reducing future strokes without increasing bleeding risks. Asundexian is developed by Bayer AG and might prevent thrombosis without increasing bleeding.
Trials With No Placebo
Behavioural Intervention
Mobile Health Rehabilitation for Heart Disease
Recruiting1 award4 criteria
New York, New York
This trial aims to see if a mobile health program can help improve heart function in older adults compared to traditional care. A total of 400 patients will be enrolled and followed for at least 3 months.
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Recruiting2 awardsPhase 3
Austin, Texas
This trial is testing whether it's better to start taking a blood thinner right away or wait a few days after having a stroke. It will also look at whether there are different results for different subgroups of people.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.